News
Zacks Investment Research on MSN13h
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre ExpansionAbbott’s ABT diversified business portfolio appears to be well-positioned to drive continued momentum in 2025. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving ABT Shares Within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback